Takeda Pharmaceutical TAK
NYSE TAK
$18.19 -0.33 (-1.78%)
At close: Sep 30, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Capital Leases (2017 - 2019)

Updated

Takeda Pharmaceutical (TAK) recorded Capital Leases of -$356.7 million in the quarter ended Mar 31, 2019, compared with -$24.52 million a year earlier.

Analysis

Takeda Pharmaceutical (TAK) Capital Leases (2017 - 2019) Analysis & Trends

Starting with the quarter ended Mar 31, 2018, Takeda Pharmaceutical's Capital Leases history includes 5 quarters.

  • Across earlier years, Capital Leases came in at -$23.99 million in the year ended Mar 31, 2018.
  • Per Business Quant, the preceding three quarters came in at -$187.06 million (quarter ended Dec 31, 2018), -$131.26 million (quarter ended Sep 30, 2018) and -$68.48 million (quarter ended Jun 30, 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -356.70 Mn
Dec 31, 2018 -187.06 Mn
Sep 30, 2018 -131.26 Mn
Jun 30, 2018 -68.48 Mn
Mar 31, 2018 -24.52 Mn
Dec 31, 2017 -17.20 Mn
API Access

Takeda Pharmaceutical Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=TAK&period=max&api_key=YOUR_API_KEY